SHARE-BASED COMPENSATION - Summary of Warrant Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 26, 2016	Dec. 27, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of warrants, exercisable		133,833
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Exercise Price [Roll Forward]
Exercisable warrants, weighted average exercise price (in dollars per share)		$ 10.21
Warrant
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of warrants, outstanding, beginning balance	133,833
Number of warrants, granted	32,250
Number of warrants, outstanding, ending balance	166,083	133,833
Number of warrants, exercisable	133,833
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Exercise Price [Roll Forward]
Outstanding warrants, weighted average exercise price, beginning balance (in dollars per share)	$ 10.21
Granted warrants, weighted average exercise price (in dollars per share)	16.80
Outstanding warrants, weighted average exercise price, ending balance (in dollars per share)	11.49	$ 10.21
Exercisable warrants, weighted average exercise price (in dollars per share)	$ 10.21
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Warrants outstanding, weighted average remaining contractual life	3 years 5 months 1 day	3 years 6 months 15 days
Warrants granted, weighted average remaining contractual life	4 years 11 months 9 days
Warrants exercisable, weighted average remaining contractual life	3 years 18 days	3 years 6 months 15 days
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Intrinsic Value [Roll Forward]
Outstanding warrants, intrinsic value, beginning balance	$ 634
Granted warrants, intrinsic price	0
Outstanding warrants, intrinsic value, ending balance	806	$ 634
Exercisable warrants, intrinsic price	$ 806	$ 634
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Nonvested, Weighted Average Grant Date Fair Value [Abstract] [Roll Forward]
Nonvested number of shares	32,250	0
Nonvested warrants, weighted average grant date fair value	0.00	0.00